Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Postoperative Complications 1Neoplasms 1Gallbladder Neoplasms 1Female Breast Cancer 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Agnosia 1

Interventions

Gemcitabine 6Cisplatin 5infigratinib 2Platinum 2Fluorouracil 21,2-diaminocyclohexaneplatinum II citrate 2ricolinostat 1niraparib 1lenvatinib 1galactomannan 1fludarabine 1famitinib 1dostarlimab 1atezolizumab 1aldesleukin 1Taxes 1Standard of Care 1Sildenafil Citrate 1Sevoflurane 1Photochemotherapy 1Oxaliplatin 1Observation 1NVP-BKM120 1Interviews as Topic 1IMC-001 1Electroporation 1Desflurane 1Cyclophosphamide 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Cholangiocarcinoma × Sevoflurane × Clear all
NCT02174575 2023-05-03

Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery

Tokyo Medical and Dental University

Phase 4 Withdrawn
Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡